Pharmaceutical industry innovation and developments /
I tiakina i:
| Kaituhi rangatōpū: | |
|---|---|
| Ētahi atu kaituhi: | , |
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
Hauppauge, N.Y. :
Nova Science,
c2011.
|
| Rangatū: | Business issues, competition and entrepreneurship series.
Pharmacology-research, safety testing, and regulation series. |
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Rārangi ihirangi:
- Authorized generic pharmaceuticals : effects on innovation / John R. Thomas
- Authorized generics : an interim report / FTC
- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context"
- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht
- Pharmaceutical R&D and the evolving market for prescription drugs / CBO
- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther
- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas
- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman
- Promotional spending for prescription drugs / CBO.